Back

Expert panel: What are the implications for our practice?

22 May 2022 (18:20 - 18:35)
Organised by:
Congress Presentation Part of: When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment options Treatment Open Access Heart Failure 2022

About the speakers

Photo
Professor John J V McMurray

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

Photo
Professor Carolyn S P Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)

Photo
Professor Scott Solomon

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

3 More presentations in this session

Presentation thumbnail
The clinical challenges of initiating guideline-recommended therapy in HFrEF.
Professor J. McMurray (Glasgow, GB)
Slides Video
Presentation thumbnail
Benefits and evolving insights on SGLT2i in the spectrum of LVEF: can we set priorities?
Professor C. Lam (Singapore, SG)
Slides Video
Presentation thumbnail
Expanding evidence on SGLT2i: where are we now and what can we expect?
Professor S. Solomon (Boston, US)
Slides Video

Access the full session

Session thumbnail
When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment options
Video

The Event

Event poster

Heart Failure 2022

22 May 2022 18:20 CET
You may be interested in
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
thumbnail
Congress Session
Which device might help your HFpEF patient?
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources